George O'Connor is a Respiratory physician affiliated with Boston University. OpenAlex indexes 666 publications with 47,548 citations (h-index 111); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
725 Albany St
Shapiro 9, Suite B
Boston, MA 021182526
Telephone
617-638-7480Provider last certified this registry record 3 Apr 2020.
Clinical trials
3 registered studies on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
84.5%Corticosteroid36.8%Dulera27%Fluticasone Propionate24%Budesonide-Formoterol Fumarate18%Fluticasone Propionate Hfa10%Arnuity Ellipta10%Symbicort6%Breo Ellipta6%Part D<11 patientsbeta2-Adrenergic Agonist19.4%Albuterol Sulfate Hfa68%Ventolin Hfa32%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
10.5%Corticosteroid7.3%Prednisone100%Part D≥21 patientsH2 blocker3.1%Famotidine100%Part D<11 patientsAnti-infectives
2.8%Tetracycline-class Drug2.8%Doxycycline Hyclate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
15 NIH research awards on record, funded 1985–2024 per NIH RePORTER. The latest:
- All of Us New England Remote Enrollment and Engagement, Nutrition for Precision Health Support
Massachusetts General Hospital
FY2024$2,000,000OT2OD037638 - The New England Precision Medicine Consortium of the All of Us Research Program
Massachusetts General Hospital
FY2023$6,925,000OT2OD026553 - The New England Precision Medicine Consortium of the All of Us Research Program
Massachusetts General Hospital
FY2022$9,700,000OT2OD026553
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2
Journal of Allergy and Clinical Immunology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Holick, MD
Boston University
Gene Kwan, MD
Boston University
Joseph Antin, MD
Boston University
Gary Balady, MD
Boston University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”